Finance

Lists
G1G:FRA
Zelira Therapeutics Ltd
€0.30
0.00%
(0.00) 1D
Feb 27, 9:11:07 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for G1G...
Mkt. cap
6.57M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.51
52-wk low
€0.17
No. of employees
8
Mkt. cap
6.57M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.51
52-wk low
€0.17
No. of employees
8
News stories
From web sources and news partners
About Zelira Therapeutics Ltd
CEOOludare Odumosu
Employees8
Founded2003
Headquarters-
SectorPharmaceutical industry
Websitezeliratx.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
328.00
328.00
-
-
Cost of goods sold
1.38K
1.38K
400.42K
400.42K
Cost of revenue
1.38K
1.38K
400.42K
400.42K
Research and development expenses
705.93K
705.93K
626.38K
626.38K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
521.79K
521.79K
314.23K
314.23K
Operating expense
729.85K
729.85K
1.03M
1.03M
Total operating expenses
731.23K
731.23K
1.43M
1.43M
Operating income
-730.90K
-730.90K
-1.43M
-1.43M
Other non operating income
-85.97K
-85.97K
525.32K
525.32K
EBT including unusual items
-1.24M
-1.24M
-682.66K
-682.66K
EBT excluding unusual items
-1.24M
-1.24M
-682.66K
-682.66K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
47.85K
47.85K
1.39K
1.39K
Net income
-1.21M
-1.21M
-608.62K
-608.62K
Net profit margin
-367,475.61%
-367,475.61%
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
221.69K
221.69K
Interest expense
-425.30K
-425.30K
-
-
Net interest expenses
-425.30K
-425.30K
221.69K
221.69K
Depreciation and amortization charges
75.05K
75.05K
60.19K
60.19K
EBITDA
-686.81K
-686.81K
-1.40M
-1.40M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps